HTFL Quote, Financials, Valuation and Earnings

National Research Corp. has a net margin of -109.9% compared to HeartFlow, Inc.'s net margin of 11.54%. HeartFlow, Inc.'s return on equity of -4298.15% beat National Research Corp.'s return on equity of 61.55%.

HeartFlow, Inc. has a consensus price target of $38.60, signalling upside risk potential of 33.4%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that HeartFlow, Inc. has higher upside potential than National Research Corp., analysts believe HeartFlow, Inc. is more attractive than National Research Corp..

HeartFlow, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

HeartFlow, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.94% to investors and pays a quarterly dividend of $0.12 per share. HeartFlow, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HeartFlow, Inc. quarterly revenues are $46.3M, which are larger than National Research Corp. quarterly revenues of $34.6M. HeartFlow, Inc.'s net income of -$50.9M is lower than National Research Corp.'s net income of $4M. Notably, HeartFlow, Inc.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 23.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartFlow, Inc. is 15.49x versus 2.67x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Predictive Oncology, Inc. has a net margin of -109.9% compared to HeartFlow, Inc.'s net margin of -2156852.78%. HeartFlow, Inc.'s return on equity of -4298.15% beat Predictive Oncology, Inc.'s return on equity of -1065.31%.

HeartFlow, Inc. has a consensus price target of $38.60, signalling upside risk potential of 33.4%. On the other hand Predictive Oncology, Inc. has an analysts' consensus of -- which suggests that it could grow by 721.92%. Given that Predictive Oncology, Inc. has higher upside potential than HeartFlow, Inc., analysts believe Predictive Oncology, Inc. is more attractive than HeartFlow, Inc..

HeartFlow, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Predictive Oncology, Inc. has a beta of 1.354, suggesting its more volatile than the S&P 500 by 35.357%.

HeartFlow, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Predictive Oncology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartFlow, Inc. pays -- of its earnings as a dividend. Predictive Oncology, Inc. pays out -- of its earnings as a dividend.

HeartFlow, Inc. quarterly revenues are $46.3M, which are larger than Predictive Oncology, Inc. quarterly revenues of $3.6K. HeartFlow, Inc.'s net income of -$50.9M is higher than Predictive Oncology, Inc.'s net income of -$77.6M. Notably, HeartFlow, Inc.'s price-to-earnings ratio is -- while Predictive Oncology, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartFlow, Inc. is 15.49x versus 16.78x for Predictive Oncology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -109.9% compared to HeartFlow, Inc.'s net margin of 9.46%. HeartFlow, Inc.'s return on equity of -4298.15% beat Spok Holdings, Inc.'s return on equity of 10.88%.

HeartFlow, Inc. has a consensus price target of $38.60, signalling upside risk potential of 33.4%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 61.17%. Given that Spok Holdings, Inc. has higher upside potential than HeartFlow, Inc., analysts believe Spok Holdings, Inc. is more attractive than HeartFlow, Inc..

HeartFlow, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

HeartFlow, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.59% to investors and pays a quarterly dividend of $0.31 per share. HeartFlow, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

HeartFlow, Inc. quarterly revenues are $46.3M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. HeartFlow, Inc.'s net income of -$50.9M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, HeartFlow, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartFlow, Inc. is 15.49x versus 1.94x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Tempus AI, Inc. has a net margin of -109.9% compared to HeartFlow, Inc.'s net margin of -23.93%. HeartFlow, Inc.'s return on equity of -4298.15% beat Tempus AI, Inc.'s return on equity of -81.31%.

HeartFlow, Inc. has a consensus price target of $38.60, signalling upside risk potential of 33.4%. On the other hand Tempus AI, Inc. has an analysts' consensus of $91.42 which suggests that it could grow by 19.77%. Given that HeartFlow, Inc. has higher upside potential than Tempus AI, Inc., analysts believe HeartFlow, Inc. is more attractive than Tempus AI, Inc..

HeartFlow, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tempus AI, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

HeartFlow, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tempus AI, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartFlow, Inc. pays -- of its earnings as a dividend. Tempus AI, Inc. pays out 0.8% of its earnings as a dividend. Tempus AI, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HeartFlow, Inc. quarterly revenues are $46.3M, which are smaller than Tempus AI, Inc. quarterly revenues of $334.2M. HeartFlow, Inc.'s net income of -$50.9M is higher than Tempus AI, Inc.'s net income of -$80M. Notably, HeartFlow, Inc.'s price-to-earnings ratio is -- while Tempus AI, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartFlow, Inc. is 15.49x versus 11.76x for Tempus AI, Inc.. Usually stocks with elevated PS ratios are considered overvalued.